Cochrane South Africa’s (CSA) Research Methods Portfolio team, under the leadership of Ameer Hohlfeld, hosted a successful two-day workshop on the 17-18 September 2025 the South African Medical Research Council’s (SAMRC) Conference Centre, bringing together post-graduate students and researchers from within the SAMRC and universities across the country, including University of Limpopo, Stellenbosch University, University of the Western Cape, University of Cape Town, University of Johannesburg, and University of Zulul

  

We are delighted to share that Cochrane’s first open access journal, Cochrane Evidence Synthesis and Methods, has published its first articles.<

Cochrane London 2023: Forward together for trusted evidence 4-6 September 2023 Central London, UK

Read the latest edition of the Cochrane SA newsletter.

In this free course, learn how you can talk about vaccines with anyone!

Cochrane review of COVID-19 vaccines shows they are effective A comprehensive review of all the evidence available from randomised controlled trials of COVID 19 vaccines up to November 2021 has concluded that most protect against infection and severe or critical illness caused by the virus.

In November 2022 Jimmy Volmink, the 'father of evidence-based medicine in Africa'  and founding Director of the South African Cochrane Centre was the speaker for the 2022 Cochrane lecture.

Key messages  1. When a patient presents with symptoms of an airway infection at the doctor's office, the doctor's use of C-reactive protein point-of-care tests during the visit probably reduces the number of patients given an antibiotic prescription, without affecting patient recovery. 2. We do not know if procalcitonin point-of-care tests have an effect on antibiotic use or patient recovery.